LLY · 10-Q · 2026Q1 · Full report
Acquisition Commitments $12B
ELI LILLY & Co · 2026-04-30 · Importance 71 · Surprise 60 · In source text
Lilly disclosed that as part of its 2026 business development activities it has entered into acquisition agreements subject to closing conditions. Potential amounts payable at closing for these pending acquisitions would be up to approximately $12 billion. These pending acquisition obligations are material relative to Lilly's balance sheet and could affect liquidity, leverage, and strategic positioning upon closing. Management flags business development as a continuing component of its growth strategy, subject to regulatory and closing risks.
Key facts
- As part of our business development activities in 2026, we have entered into acquisition agreements, subject to closing conditions, with potential amounts payable at closing for these pending acquisitions of up to approximately $12 billion. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| liability | negative | probable | -2.6% | As part of our business development activities in 2026, we have entered into acquisition agreements, subject to closing conditions, with… |